|1.||Bauer, Joseph A: 6 articles (09/2012 - 07/2002)|
|2.||Lindner, Daniel J: 4 articles (01/2007 - 07/2002)|
|3.||Morrison, Bei H: 3 articles (01/2007 - 07/2002)|
|4.||Lupica, Joseph A: 2 articles (01/2007 - 10/2003)|
|5.||Tang, Zhuo: 2 articles (08/2006 - 10/2003)|
|6.||Oh, Y M: 1 article (01/2014)|
|7.||Song, Y-J: 1 article (01/2014)|
|8.||Choi, J: 1 article (01/2014)|
|9.||Kim, B: 1 article (01/2014)|
|10.||Han, Y K: 1 article (01/2014)|
01/01/2007 - "The specific aims of this study were to 1) measure the anti-tumor effects of NO-Cbl alone and in combination with conventional chemotherapeutic agents, and to 2) examine the mechanism of action of NO-Cbl as a single agent and in combination therapy. "
01/02/2014 - "Furthermore, SAIT301 was able to downregulate Met and dramatically inhibit growth of tumors with low or no Cbl expression, as well as tumors with Met exon 14 deletion that prevents Met binding to Cbl. "
10/01/2010 - "(2) The Golden Retriever demonstrated a 53% reduction in tumor volume after 15 months of daily NO-Cbl therapy. "
10/01/2010 - "(1) The Giant Schnauzer demonstrated a 77% reduction in tumor volume after ten weeks of daily NO-Cbl treatment. "
10/10/2003 - "The use of NO-Cbl and Apo2L/TRAIL capitalizes on the tumor-specific properties of both agents and represents a promising anti-cancer combination."
|2.||Melanoma (Melanoma, Malignant)
10/10/2003 - "The specific aim of this study was to examine whether NO-Cbl could sensitize drug-resistant melanomas to Apo2L/TRAIL. "
10/10/2003 - "NO-Cbl sensitized Apo2L/TRAIL-resistant melanoma cell lines to growth inhibition by Apo2L/TRAIL but had minimal effect on normal cell lines. "
10/10/2003 - "Antiproliferative effects of NO-Cbl and Apo2L/TRAIL were assessed in malignant melanomas and non-tumorigenic melanocyte and fibroblast cell lines. "
10/10/2003 - "Athymic nude mice bearing human melanoma A375 xenografts were treated with NO-Cbl and Apo2L/TRAIL. "
08/01/2006 - "Human melanoma (A375), renal carcinoma (ACHN), and ovarian carcinoma (NIH-OVCAR-3) cells were treated with NO-Cbl and subjected to the biotin switch assay; S-nitrosylated DR4 was detected in all three cell lines. "
|3.||Ovarian Neoplasms (Ovarian Cancer)
|1.||Vitamin B 12 (Cyanocobalamin)
|3.||Nitric Oxide (Nitrogen Monoxide)
|4.||Caspase 8 (Caspase-8)
|5.||Caspase 3 (Caspase-3)
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|8.||Biotin (Vitamin H)
|9.||Aligeron (AS 2)
|1.||Heterologous Transplantation (Xenotransplantation)